NFA
TGTX icon

Nationwide Fund Advisors’s TG Therapeutics TGTX Stock Holding History

Nationwide Fund Advisors’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-26,531
Closed -$314K – 1882
2017
Q3 		$314K Hold
26,531
– – ﹤0.01% 2419
2017
Q2 		$267K Buy
26,531
+5,167
+24% +$57.8K ﹤0.01% 2502
2017
Q1 		$249K Sell
21,364
-56,767
-73% -$407K ﹤0.01% 2487
2016
Q4 		$363K Sell
78,131
-27,718
-26% -$163K ﹤0.01% 2344
2016
Q3 		$819K Sell
105,849
-3,055
-3% -$19.6K ﹤0.01% 1905
2016
Q2 		$660K Buy
108,904
+86,573
+388% +$704K ﹤0.01% 1986
2016
Q1 		$207K Sell
22,331
-1,170
-5% -$10.2K ﹤0.01% 2525
2015
Q4 		$280K Buy
23,501
+613
+3% +$7.74K ﹤0.01% 2390
2015
Q3 		$231K Hold
22,888
– – ﹤0.01% 2490
2015
Q2 		$380K Buy
22,888
+2,543
+12% +$40.3K ﹤0.01% 2403
2015
Q1 		$315K Sell
20,345
-380
-2% -$5.75K ﹤0.01% 2472
2014
Q4 		$328K Buy
20,725
+2,708
+15% +$35.3K ﹤0.01% 2413
2014
Q3 		$192K Buy
18,017
+57
+0.3% +$529 ﹤0.01% 2710
2014
Q2 		$169K Buy
17,960
+4,918
+38% +$31.4K ﹤0.01% 2829
2014
Q1 		$90K Buy
13,042
+822
+7% +$4.87K ﹤0.01% 2771
2013
Q4 		$48K Hold
12,220
– – ﹤0.01% 3066
2013
Q3 		$62K Buy
12,220
+8,173
+202% +$50K ﹤0.01% 3027
2013
Q2 		$26K Buy
+4,047
New +$25.9K ﹤0.01% 3062

Other funds holding TGTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Nationwide Fund Advisors's TGTX Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of TG Therapeutics (TGTX) in Q4 2017, closing a stake of 26,531 shares — an estimated $314K sold.

Nationwide Fund Advisors first reported a position in TGTX in Q2 2013 and held it in 18 quarters. The position peaked at $819K in Q3 2016. 109 funds tracked by Wall St. Rank hold TGTX as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining TG Therapeutics position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 26,531 TG Therapeutics shares in Q4 2017, an estimated $314K.
  • Nationwide Fund Advisors first reported a position in TG Therapeutics in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's TG Therapeutics position peaked at $819K in Q3 2016.
  • 109 funds tracked by Wall St. Rank held TG Therapeutics as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.